Ledger.Open graph →
SEC Form D · filed October 1, 2018

Propanc Biopharma, Inc

Offering
$6.3M
Sold
$6.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBERWELL, VIC, Channel Islands
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

James Nathanielsz · Camberwell, VIC, Channel IslandsExec · DirectorJulian Kenyon · Camberwell, VC, Channel IslandsDirectorJacob Abikzer · West Palm Beach, FLDirectorFrancis E. Kenney · Woburn, MAExec · DirectorPeter A. Hirth · South San Francisco, CAExec · DirectorKaylen A. Farmer · Denton, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗